)
Abid S. Ansari, CPA
Chief Financial Officer
BIO Member
Abid brings over 20 years of experience in the biotechnology and life sciences industries, including eight years as a biotech CFO. He has successfully raised over $450M through equity transactions, including a $153M Series C at Artios and a $146M IPO at Precision BioSciences. Earlier in his career, he held positions at GlaxoSmithKline (GSK) in deal finance and portfolio management. While at GSK, Abid played a key role in several transactions, including the acquisition of Bristol Myers Squibb’s (BMS) HIV portfolio, the asset sale of ofatumumab to Novartis, and a strategic research collaboration and licensing agreement with Adaptimmune. Additionally, Abid previously held commercial and capital finance roles at MedImmune LLC. Abid graduated from Purdue University with a Bachelor of Science in Chemical Engineering and a Master of Business Administration. He is a Certified Public Accountant in the state of Delaware.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}